The current drug development process operates like an assembly line, relying on a checkbox approach with extensive testing at ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Obesity continues to grab attention at the J.P. Morgan Healthcare Conference in San Francisco, with both Pfizer and Kailera ...

Researchers at the University of Oklahoma have developed a breakthrough method of adding a single nitrogen atom to molecules, ...

Marea’s Phase IIa study enrolled patients with hypertriglyceridemia—too much fat in the blood. The latest results showed the ...

Azafaros B.V. today announced that its lead asset, nizubaglustat, has been granted orphan drug designation from regulatory authorities in both the United States and the European Union for the ...

Psilocybin is under clinical development by Filament Health and currently in Phase I for Substance (Drug) Abuse.